English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

The infamous GlaxoSmithKline (GSK) bribery case of 2013 led to the emergence of compliance management as a local strategic response to ensuring compliance with regulations in the transnational pharmaceutical corporations within China. However, China's pharmaceutical industry has a long history of practicing the corrupt customs of  “ drug-incentivizing medicine” ( yiyao buyi ) and “ guanxi- based sales” ( guanxi xiaoshou ), which are, obviously, at odds with the highest ethical standards for compliance management as well as the principle of the anti-corruption campaign of the current Chinese administration. Based upon an in-depth ethnographic work from China's pharmaceutical industry, this article proposes a new framework to examine the complicated dynamics of interaction between the state's anti-corruption policy, corrupt long-standing customary industrial practices, local cultural practice, and global compliance management norms in post-socialist spaces. Different from some studies that focus on the resistance to global norms by local forces, this study suggests a reverse direction and focuses on the positive reconstruction of the old socialist ideals and corrupt practices by modern disciplinary institutions with the capitalist work ethic in the Chinese workplace.

inter-asia cultural studies

The new dynamics between the state, local ideals, and (anti-)corruption: an ethnographic study of the ethical practices of China's pharmaceutical industry